What does Mphasis do?

Mphasis Ltd. is a global IT solutions provider specializing in cloud and cognitive services, with a market cap of Rs 48,429 Cr and reported net sales of 3,710 Cr and net profit of 446 Cr for the quarter ending March 2025. The company has a P/E ratio of 28.00 and a dividend yield of 2.17%.

Overview:<BR>Mphasis Ltd. is a global Information Technology solutions provider specializing in cloud and cognitive services, operating within the Computers - Software & Consulting industry and classified as a Large Cap company.<BR><BR>History:<BR>Mphasis Limited was incorporated on 10 August 1992. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 3,710 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 446 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 48,429 Cr (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 28.00<BR>- Industry P/E: 29<BR>- Dividend Yield: 2.17%<BR>- Debt Equity: -0.16<BR>- Return on Equity: 17.68%<BR>- Price to Book: 4.99<BR><BR>Contact Details:<BR>- Address: Bagmane World Tech Center, Marathalli RingRd Mahadevapura Bengaluru Karnataka : 560048<BR>- Tel: 91-80-6750 1000<BR>- Email: investor.relations@mphasis.com<BR>- Website: http://www.mphasis.com

When is the next results date for Mphasis?

No Upcoming Board Meetings

Has Mphasis declared dividend?

Yes, Mphasis Ltd. has declared a dividend of 550%, amounting to ₹55 per share, with an ex-date of July 10, 2024. The company has shown varying total returns over different periods, with a notable 201.92% total return over the last 5 years.

Mphasis Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 550%<BR>- Amount per share: 55<BR>- Ex-date: 10 Jul 24<BR><BR>Dividend Yield: 2.17%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, Mphasis experienced a price return of -16.89%, with no dividend return, resulting in a total return of -16.89%.<BR><BR>Over the past year, the company saw a price return of 4.28% and a dividend return of 2.30%, leading to a total return of 6.58%.<BR><BR>In the 2-year period, Mphasis achieved a price return of 32.72% and a dividend return of 2.94%, culminating in a total return of 35.66%.<BR><BR>For the 3-year period, the price return was 0.13% with a dividend return of 4.43%, resulting in a total return of 4.56%.<BR><BR>In the 4-year timeframe, Mphasis recorded a price return of 32.96% and a dividend return of 6.24%, yielding a total return of 39.2%.<BR><BR>Over the last 5 years, the company experienced a remarkable price return of 187.21% along with a dividend return of 14.71%, leading to an impressive total return of 201.92%.<BR><BR>Overall, Mphasis has declared a substantial dividend, and despite some fluctuations in price returns, the total returns over various periods indicate a generally positive performance, particularly over the long term.

Who are the peers of the Mphasis?

Mphasis's peers include TCS, Infosys, HCL Technologies, Wipro, Tech Mahindra, L&T Technology, Tata Elxsi, KPIT Technologies, and Tata Technologies. Mphasis has a good management risk and capital structure, with a 1-year return of 9.42%, lower than HCL Technologies (24.57%) but higher than Tata Technologies (-25.58%).

Peers: The peers of Mphasis are TCS, Infosys, HCL Technologies, Wipro, Tech Mahindra, L&T Technology, Tata Elxsi, KPIT Technologi., and Tata Technolog.<BR><BR>Quality Snapshot: Excellent management risk is observed at TCS, Infosys, HCL Technologies, L&T Technology, Tata Elxsi, KPIT Technologi., and Tata Technolog., while Good management risk is found at Wipro, Tech Mahindra, and Mphasis. Growth is rated as Excellent for KPIT Technologi., Good for TCS and Infosys, Average for HCL Technologies, L&T Technology, Tata Elxsi, and Tata Technolog., and Below Average for Wipro, Tech Mahindra, and Mphasis. All peers have an Excellent capital structure except for Mphasis, which has a Good capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is HCL Technologies at 24.57%, while Tata Technolog. has the lowest at -25.58%. Mphasis has a 1-year return of 9.42%, which is higher than Tata Technolog. but lower than HCL Technologies. Additionally, Wipro, Tech Mahindra, L&T Technology, and Tata Technolog. all have negative six-month returns.

Is Mphasis overvalued or undervalued?

As of July 11, 2025, Mphasis is considered overvalued with a PE ratio of 31.53, significantly higher than its peers TCS and Infosys, and has recently declined by 3.56%, indicating a premium valuation compared to its earnings growth potential.

As of 11 July 2025, Mphasis has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE ratio of 31.53, an EV to EBIT of 24.03, and a PEG ratio of 3.60, all of which suggest that the stock is trading at a premium compared to its earnings growth potential.<BR><BR>In comparison to its peers, Mphasis's PE ratio is significantly higher than TCS, which stands at 23.98, and Infosys, with a PE of 24.8. This indicates that Mphasis is priced at a higher multiple relative to its earnings than these competitors. Notably, the company's recent stock performance has shown a decline of 3.56% over the past week, while the Sensex has only decreased by 1.12%, further reinforcing the notion that Mphasis may be overvalued in the current market environment.

Who are in the management team of Mphasis?

As of March 2023, Mphasis' management team includes Nitin Rakesh (Managing Director & CEO), Davinder Singh Brar (Chairman), and several directors, both executive and independent, who guide the company's governance and strategy.

As of March 2023, the management team of Mphasis includes the following individuals:<BR><BR>1. Nitin Rakesh - Managing Director & CEO<BR>2. Subramanian Narayan - Senior Vice President & CS<BR>3. Davinder Singh Brar - Chairman & Independent Director<BR>4. Narayanan Kumar - Independent Director<BR>5. Jan Kathleen Hier - Independent Director<BR>6. David Lawrence Johnson - Director<BR>7. Amit Dixit - Director<BR>8. Amit Dalmia - Director<BR>9. Marshall Jan Lux - Director<BR>10. Kabir Mathur - Director<BR>11. Courtney Della Cava - Director<BR>12. Maureen Anne Erasmus - Independent Director<BR>13. Pankaj Sood - Director<BR><BR>This team comprises a mix of executive leadership and independent directors, contributing to the governance and strategic direction of the company.

Who are the top shareholders of the Mphasis?

The top shareholders of Mphasis include Bcp Topco Ix Pte. Ltd. with 40.14%, mutual funds with 22.95%, and Foreign Institutional Investors (FIIs) at 20.61%. The largest public shareholder is the Kotak Emerging Equity Scheme, holding 7.19%, while individual investors own 3.22%.

The top shareholders of Mphasis include several key players. The majority shareholder is Bcp Topco Ix Pte. Ltd., which holds a significant 40.14% of the company. Additionally, mutual funds collectively hold 22.95% of the shares, represented by 221 schemes. Foreign Institutional Investors (FIIs) own 20.61%, with 718 FIIs participating in the ownership. The highest public shareholder is the Kotak Emerging Equity Scheme, which accounts for 7.19%. Individual investors hold a smaller portion, at 3.22%.

How big is Mphasis?

As of 24th July, Mphasis Ltd. has a market capitalization of 51,320.00 Cr, with recent net sales of 14,229.99 Cr and a net profit of 1,702.14 Cr. The company reported shareholder's funds of 9,628.40 Cr and total assets of 14,582.02 Cr.

As of 24th July, Mphasis Ltd. has a market capitalization of 51,320.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest 4 quarters, Mphasis reported Net Sales of 14,229.99 Cr and a Net Profit of 1,702.14 Cr.<BR><BR>For the latest annual period, Mphasis recorded Shareholder's Funds of 9,628.40 Cr and Total Assets amounting to 14,582.02 Cr.

Are Mphasis latest results good or bad?

Mphasis's latest results are mixed; while they achieved record quarterly net sales and improved liquidity, net sales growth slowed to 0.61% and net profit declined by 1.07%, indicating potential concerns in overall performance.

Mphasis's latest results present a mixed picture. On one hand, the company achieved its highest quarterly net sales at Rs 3,732.49 crore, indicating consistent growth over the last five quarters. Additionally, the operating profit before depreciation, interest, and taxes (PBDIT) reached a peak of Rs 702.87 crore, which reflects a positive trend in operating profitability. The cash and cash equivalents also improved, reaching Rs 1,612.58 crore, suggesting better short-term liquidity.<BR><BR>On the other hand, the overall performance has shown signs of decline. The net sales growth was only 0.61%, down from 4.18% in the previous quarter, and the consolidated net profit saw a decrease of 1.07%. Furthermore, the debtors turnover ratio fell to 5.01 times, indicating challenges in settling debts, and while non-operating income increased, its sustainability is uncertain.<BR><BR>In summary, while there are positive aspects such as record sales and improved liquidity, the declining growth rates and challenges in debt management suggest that the overall results could be viewed as concerning.

How has been the historical performance of Mphasis?

Mphasis has shown consistent growth in net sales and profitability, with net sales increasing from 7,730.98 Cr in March 2019 to 14,229.99 Cr in March 2025, and profit after tax rising from 1,073.35 Cr to 1,702.14 Cr during the same period. Key financial metrics indicate robust health, with significant improvements in operating profit and earnings per share.

Answer:<BR>The historical performance of Mphasis shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Mphasis has demonstrated a steady increase in net sales, rising from 7,730.98 Cr in March 2019 to 14,229.99 Cr in March 2025. The total operating income has followed a similar trend, reaching 14,229.99 Cr in March 2025, up from 7,730.98 Cr in March 2019. Operating profit (PBDIT) has also shown growth, climbing from 1,500.54 Cr in March 2019 to 2,901.99 Cr in March 2025. Profit before tax increased from 1,407.33 Cr in March 2019 to 2,260.14 Cr in March 2025, while profit after tax rose from 1,073.35 Cr to 1,702.14 Cr in the same period. The company's earnings per share (EPS) improved significantly, from 57.64 in March 2019 to 89.55 in March 2025. On the balance sheet, total assets grew from 8,537.75 Cr in March 2019 to 14,582.02 Cr in March 2025, with total liabilities also increasing from 6,407.15 Cr to 14,582.02 Cr. Cash flow from operating activities peaked at 1,905.00 Cr in March 2025, reflecting strong operational efficiency. Overall, Mphasis has shown robust financial health and growth across key metrics over the years.

Is Mphasis technically bullish or bearish?

As of November 24, 2025, Mphasis shows a mildly bullish trend based on daily moving averages and Bollinger Bands, despite some bearish signals from MACD and KST on weekly and monthly charts.

As of 24 November 2025, the technical trend for Mphasis has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the Bollinger Bands are bullish on both weekly and monthly time frames. However, the MACD, KST, and OBV show a mildly bearish trend on the weekly and monthly charts, suggesting some underlying weakness. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and Bollinger Bands, despite the bearish signals from MACD and KST.

Should I buy, sell or hold Mphasis Ltd.?

Which are the latest news on Mphasis?

Which are the latest news on Mphasis?

Why is Mphasis falling/rising?

As of 22-Dec, Mphasis Ltd. is seeing a stock price decline to 2,879.00, down 0.44%. This drop follows three days of gains and reflects underperformance against its sector, despite a recent increase in investor participation.

As of 22-Dec, Mphasis Ltd. is experiencing a decline in its stock price, currently at 2,879.00, reflecting a change of -12.6 or -0.44%. This downward movement can be attributed to several factors. Firstly, the stock has underperformed its sector by 2.15% today, indicating a relative weakness compared to its peers. Additionally, the stock has fallen after three consecutive days of gains, suggesting a trend reversal.<BR><BR>Intraday, the stock reached a low of Rs 2817.7, marking a decrease of 2.56%. Although the stock is trading higher than its 20-day, 50-day, 100-day, and 200-day moving averages, it is currently lower than its 5-day moving average, which may indicate short-term selling pressure.<BR><BR>Despite these negative indicators, there are some positive aspects to consider. The stock has shown a 4.82% increase over the past month, and there has been a notable rise in investor participation, with delivery volume increasing by 79.95% against the 5-day average. However, the current performance and recent trend suggest that the stock is facing challenges that are contributing to its decline.

Why is Mphasis Ltd. falling/rising?

As of 23-Dec, Mphasis Ltd. is seeing a stock price increase to 2,934.00, driven by strong momentum and heightened investor interest, with significant gains in delivery volume and robust financial health. Despite some risks, positive performance metrics and institutional backing support the stock's rise.

As of 23-Dec, Mphasis Ltd. is experiencing a rise in its stock price, currently at 2,934.00, reflecting an increase of 46.8 (1.62%). This upward movement can be attributed to several positive factors. The stock has outperformed the sector by 2.52% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong momentum. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 165.94% against the 5-day average, suggesting heightened interest from investors.<BR><BR>Moreover, the company's financial health appears robust, with net sales reaching a record high of Rs 3,901.91 crore and cash and cash equivalents at Rs 16,157.80 crore. The high management efficiency, reflected in a return on equity (ROE) of 20.32%, and a low debt-to-equity ratio further bolster investor confidence. Institutional holdings stand at 55.59%, indicating that knowledgeable investors are backing the stock.<BR><BR>Despite some risks, such as poor long-term growth rates and a relatively high price-to-book value, the current performance metrics and positive investor sentiment contribute to the stock's rise. Overall, Mphasis Ltd. is benefiting from strong operational results and increased market interest, leading to its current upward price movement.

Why is Mphasis Ltd. falling/rising?

As of 24-Dec, Mphasis Ltd. is experiencing a stock price decline to 2,896.40, down 1.42%. This decline is attributed to underperformance relative to the market and concerns over long-term growth, despite some positive short-term returns and strong financial metrics.

As of 24-Dec, Mphasis Ltd. is experiencing a decline in its stock price, currently at 2,896.40, which reflects a change of -41.6 or -1.42%. This decrease is occurring despite the stock's recent performance over various periods, where it has shown positive returns, such as a 1.00% increase over the past week and a 4.76% increase over the past month. However, it has underperformed the sector today by -1.13%.<BR><BR>The stock's current decline can be attributed to its performance relative to the broader market, as indicated by its year-to-date return of +1.57%, which is significantly lower than the Sensex's +9.30%. Additionally, while Mphasis has shown strong financial metrics, including high net sales and cash equivalents, its long-term growth prospects are concerning. The company has reported a modest annual growth rate in net sales of 9.78% and operating profit of 8.68% over the last five years, which raises concerns about its future performance.<BR><BR>Furthermore, the stock is trading at a premium valuation with a Price to Book Value of 5.7, which is higher than its peers' average historical valuations. This expensive valuation, combined with a PEG ratio of 2.8, suggests that the stock may be overvalued relative to its earnings growth, contributing to investor caution. Overall, while there are positive factors such as high management efficiency and strong institutional holdings, the combination of underperformance against the sector, concerns about long-term growth, and high valuation metrics are likely influencing the current decline in Mphasis Ltd.'s stock price.

Why is Mphasis Ltd. falling/rising?

As of 25-Dec, Mphasis Ltd. is seeing a stock price decline to 2,896.40, down 1.42%, primarily due to underperformance in its sector. Despite this, it shows positive long-term trends and strong financial metrics, though its high valuation may cause investor caution.

As of 25-Dec, Mphasis Ltd. is experiencing a decline in its stock price, currently at 2,896.40, which reflects a change of -41.6 or -1.42%. This drop can be attributed to its performance today, where it underperformed its sector by 1.13%. Despite this, the stock has shown some positive trends in other areas; it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally upward trend over a longer period.<BR><BR>Investor participation has also increased, with a delivery volume of 4.02 lacs on 23 Dec, which is a rise of 67.6% compared to the 5-day average. However, the overall year-to-date performance shows that while Mphasis has gained 1.57%, it has underperformed relative to the Sensex, which has increased by 9.30% during the same period.<BR><BR>The company's financial metrics reveal strengths, such as a high return on equity (ROE) of 20.32% and a low debt-to-equity ratio, which could support a positive outlook. Nevertheless, the stock's valuation appears expensive, trading at a premium compared to its peers, with a price-to-book value of 5.7. This, combined with a relatively low long-term growth rate in net sales and operating profit, may contribute to investor caution, leading to the current decline in stock price.

Why is Mphasis Ltd. falling/rising?

As of 26-Dec, Mphasis Ltd. is experiencing a stock price decline to 2,842.20, down 1.73%. This is due to underperformance in its sector, decreasing investor participation, and concerns over long-term growth despite some positive indicators.

As of 26-Dec, Mphasis Ltd. is experiencing a decline in its stock price, currently at 2,842.20, which reflects a change of -50.05 (-1.73%). This downward movement is attributed to several factors. The stock has underperformed its sector by -0.78% today and has been on a consecutive decline for the last two days, resulting in a total drop of -3.26% during this period. <BR><BR>Investor participation appears to be waning, as evidenced by a significant decrease in delivery volume, which fell by -39.05% compared to the 5-day average. Although the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below the 5-day and 20-day moving averages, indicating short-term weakness.<BR><BR>Furthermore, despite some positive indicators such as high management efficiency and strong institutional holdings, the company faces risks related to poor long-term growth, with net sales growing at an annual rate of only 9.78% over the past five years. The stock is also considered expensive, trading at a premium compared to its peers, with a Price to Book Value of 5.6. This combination of factors contributes to the stock's current decline.